← SynDRA
ORBIFLOXACIN
SynDRA canonical compound SYN0002262 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | bacterial DNA gyrase inhibitor |
|---|
| Indication | urinary tract infections |
|---|
| Disease area | infectious disease |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- DUS3L
- ESRRA
- KSYK
- NF2L2
- SYK
- UBE2M
- ULA1
Cross-references
Synonyms
- Orbax
- orbax
- NSC-758614
- Orbifloxacine
- Orbifloxacino
- orbifloxacin (usp monograph)
- orbifloxacin (usp impurity)
- NSC 758614
- orbifloxacin (usp-rs)
- orbifloxacine
- orbifloxacino
- orbifloxacinum
- Orbax Tablets
- RefChem:57814
- DTXCID901777786
- MFCD00864858
- NCGC00160518-01
- CP 104354
- DTXCID5026201
- SMR000544203
- Orbifloxacin [INN]
- CAS-113617-63-3
- SR-01000790054
- Orbifloxacin [USP:INN:BAN]
- UNII-660932TPY6
- Orbifloxacin CRS
- Orbax (veterinary)
- Orbifloxacin (Standard)
- SpecPlus_000366
- Orbifloxacin (USP/INN)
- ORBIFLOXACIN [MI]
- Orbax [veterinary] (TN)
- ORBIFLOXACIN [JAN]
- ORBIFLOXACIN [MART.]
- MLS000766847
- MLS001216436
- DivK1c_006462
- ORBIFLOXACIN [USP-RS]
Look up ORBIFLOXACIN in the interactive SynDRA portal →